Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXE0SL
|
||||
| Drug Name |
(S)-N-(1-(2-(indolin-1-yl)ethylamino)-4-methyl-1-oxopentan-2-yl)-3-methylbenzamide
|
||||
| Synonyms |
CHEMBL205835
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H31N3O2
|
||||
| Canonical SMILES |
CC(C)C[C@H](NC(=O)c1cccc(C)c1)C(=O)NCCN2CCc3ccccc23
|
||||
| InChI |
InChI=1S/C24H31N3O2/c1-17(2)15-21(26-23(28)20-9-6-7-18(3)16-20)24(29)25-12-14-27-13-11-19-8-4-5-10-22(19)27/h4-10,16-17,21H,11-15H2,1-3H3,(H,25,29)(H,26,28)/t21-/m0/s1
|
||||
| InChIKey |
IYQYYEJBWONMDP-NRFANRHFSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.